• / Free eNewsletters & Magazine
  • / My Account
Home>Teva to buy Auspex in a $3.2 billion deal

Teva to buy Auspex in a $3.2 billion deal

3party Content

Mon, 30 Mar 2015

Teva Pharmaceuticals (TEVA) announced on Monday an agreement to buy Auspex Pharmaceuticals (ASPX) in a deal valued at $3.2 billion, as the Teva looks to bulk up its position in the movement disorders space. As part of the deal, Teva is offering to pay $101 a share in cash for each Auspex share
Upcoming Events

©2014 Morningstar Advisor. All right reserved.